Dann, Emma http://orcid.org/0000-0002-7400-7438
Cujba, Ana-Maria
Oliver, Amanda J. http://orcid.org/0000-0003-1690-9027
Meyer, Kerstin B. http://orcid.org/0000-0001-5906-1498
Teichmann, Sarah A. http://orcid.org/0000-0002-6294-6366
Marioni, John C. http://orcid.org/0000-0001-9092-0852
Funding for this research was provided by:
Core funding from the European Molecular Biology Laboratory.
Core funding from Wellcome Sanger Institute
Article History
Received: 9 November 2022
Accepted: 5 September 2023
First Online: 12 October 2023
Competing interests
: In the past 3 years, S.A.T. has consulted for Sanofi and has sat on the scientific advisory boards of QIAGEN, Foresite Labs and GlaxoSmithKline. She is a cofounder and equity holder of Transition Bio. From 1 September 2022, J.C.M. has been an employee of Genentech. The other authors declare no competing interests.